Stanley Laman Group Ltd. lowered its holdings in shares of Stryker Corporation (NYSE:SYK – Free Report) by 33.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 801 shares of the medical technology company’s stock after selling 401 shares during the period. Stanley Laman Group Ltd.’s holdings in Stryker were worth $317,000 as of its most recent SEC filing.
A number of other institutional investors also recently bought and sold shares of SYK. Brighton Jones LLC boosted its stake in shares of Stryker by 15.4% during the fourth quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock worth $1,643,000 after buying an additional 609 shares during the period. GAMMA Investing LLC lifted its position in Stryker by 16.4% during the 1st quarter. GAMMA Investing LLC now owns 5,574 shares of the medical technology company’s stock worth $2,075,000 after acquiring an additional 785 shares during the period. Kingswood Wealth Advisors LLC grew its stake in shares of Stryker by 21.7% in the 1st quarter. Kingswood Wealth Advisors LLC now owns 1,489 shares of the medical technology company’s stock valued at $555,000 after purchasing an additional 265 shares during the last quarter. Institute for Wealth Management LLC. acquired a new position in shares of Stryker in the first quarter valued at approximately $205,000. Finally, United Advisor Group LLC purchased a new stake in shares of Stryker during the first quarter worth approximately $219,000. 77.09% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of equities analysts have commented on SYK shares. Rothschild Redb upgraded shares of Stryker to a “hold” rating in a research report on Thursday, September 18th. BTIG Research raised their price objective on shares of Stryker from $407.00 to $408.00 and gave the company a “buy” rating in a research report on Monday, October 13th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Stryker in a report on Wednesday, October 8th. Truist Financial cut their target price on Stryker from $415.00 to $407.00 and set a “hold” rating for the company in a research note on Wednesday. Finally, Rothschild & Co Redburn initiated coverage on Stryker in a research note on Thursday, September 18th. They issued a “neutral” rating and a $420.00 price target on the stock. Fifteen research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $431.76.
Stryker Price Performance
SYK stock opened at $374.67 on Friday. The firm has a 50 day moving average of $379.40 and a 200-day moving average of $378.77. The company has a market cap of $143.24 billion, a price-to-earnings ratio of 49.63, a PEG ratio of 2.70 and a beta of 0.94. The company has a current ratio of 1.78, a quick ratio of 1.06 and a debt-to-equity ratio of 0.70. Stryker Corporation has a 12-month low of $329.16 and a 12-month high of $406.19.
Stryker (NYSE:SYK – Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.13 earnings per share for the quarter, beating the consensus estimate of $3.07 by $0.06. The firm had revenue of $6.02 billion during the quarter, compared to the consensus estimate of $5.92 billion. Stryker had a return on equity of 23.94% and a net margin of 12.25%.Stryker’s quarterly revenue was up 11.1% on a year-over-year basis. During the same period last year, the business posted $2.81 EPS. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. As a group, equities analysts expect that Stryker Corporation will post 13.47 EPS for the current fiscal year.
Stryker Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be paid a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 30th. Stryker’s payout ratio is 44.50%.
Insider Activity
In related news, insider Viju Menon sold 500 shares of the stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $390.61, for a total value of $195,305.00. Following the sale, the insider directly owned 12,511 shares of the company’s stock, valued at approximately $4,886,921.71. This represents a 3.84% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Ronda E. Stryker sold 200,000 shares of Stryker stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the transaction, the director owned 3,222,108 shares of the company’s stock, valued at approximately $1,212,962,556.60. The trade was a 5.84% decrease in their position. The disclosure for this sale can be found here. 5.90% of the stock is owned by insiders.
Stryker Company Profile
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.
Read More
- Five stocks we like better than Stryker
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Johnson & Johnson’s M&A Strategy Is the Real Story for Investors
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Tesla: Some Analysts Are Calling for A 30% Drop—Time to Panic?
- 3 Tickers Leading a Meme Stock Revival
- Hedge Funds Flip on the Dollar—A Buy Signal for These 3 Stocks?
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK – Free Report).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.